"Immunodominant Epitopes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Subunits of the antigenic determinant that are most easily recognized by the immune system and thus most influence the specificity of the induced antibody.
| Descriptor ID |
D016056
|
| MeSH Number(s) |
D23.050.550.500
|
| Concept/Terms |
Immunodominant Epitopes- Immunodominant Epitopes
- Immunodominant Determinants
- Determinants, Immunodominant
- Immunodominant Domains
- Domains, Immunodominant
- Immunodominant Sites
- Sites, Immunodominant
- Immunodominant Regions
- Regions, Immunodominant
- Antigenic Determinants, Immunodominant
- Determinants, Immunodominant Antigenic
- Immunodominant Antigenic Determinants
- Epitopes, Immunodominant
|
Below are MeSH descriptors whose meaning is more general than "Immunodominant Epitopes".
Below are MeSH descriptors whose meaning is more specific than "Immunodominant Epitopes".
This graph shows the total number of publications written about "Immunodominant Epitopes" by people in this website by year, and whether "Immunodominant Epitopes" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 5 | 2 | 7 |
| 1996 | 2 | 5 | 7 |
| 1997 | 1 | 2 | 3 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 1 | 2 |
| 2000 | 3 | 5 | 8 |
| 2001 | 2 | 2 | 4 |
| 2002 | 4 | 4 | 8 |
| 2003 | 4 | 10 | 14 |
| 2004 | 9 | 6 | 15 |
| 2005 | 4 | 8 | 12 |
| 2006 | 3 | 2 | 5 |
| 2007 | 7 | 3 | 10 |
| 2008 | 4 | 4 | 8 |
| 2009 | 4 | 3 | 7 |
| 2010 | 3 | 7 | 10 |
| 2011 | 5 | 0 | 5 |
| 2012 | 6 | 3 | 9 |
| 2013 | 1 | 4 | 5 |
| 2014 | 1 | 0 | 1 |
| 2015 | 4 | 1 | 5 |
| 2016 | 1 | 5 | 6 |
| 2017 | 3 | 4 | 7 |
| 2018 | 2 | 4 | 6 |
| 2019 | 2 | 1 | 3 |
| 2020 | 5 | 1 | 6 |
| 2021 | 4 | 4 | 8 |
| 2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Immunodominant Epitopes" by people in Profiles.
-
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature. 2023 Aug; 620(7972):128-136.
-
HLA-A∗02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses. Cell Rep. 2021 12 28; 37(13):110167.
-
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study. Science. 2021 Oct 22; 374(6566):472-478.
-
Negative feedback by NUR77/Nr4a1 restrains B cell clonal dominance during early T-dependent immune responses. Cell Rep. 2021 08 31; 36(9):109645.
-
Elevated mycobacterium avium subsp. paratuberculosis (MAP) antibody titer in Japanese multiple sclerosis. J Neuroimmunol. 2021 11 15; 360:577701.
-
HLA-E-restricted HIV-1-specific CD8+ T cell responses in natural infection. J Clin Invest. 2021 08 16; 131(16).
-
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19. Cell Host Microbe. 2021 07 14; 29(7):1076-1092.
-
A primary Chlamydia trachomatis genital infection of rhesus macaques identifies new immunodominant B-cell antigens. PLoS One. 2021; 16(4):e0250317.
-
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients. Sci Immunol. 2021 04 14; 6(58).
-
Epitope prediction and identification- adaptive T cell responses in humans. Semin Immunol. 2020 08; 50:101418.